Abasi Ene-Obong

Last updated

Dr.
Abasi Ene-Obong
Born (1985-06-20) 20 June 1985 (age 38)
Calabar, Nigeria
NationalityNigerian
Alma mater Imperial College London
Keck Graduate Institute
Barts
OccupationBusiness executive
Known for Biotechnology
Notable workCEO at 54gene
TitleFounder and CEO at Syndicate Bio
Spouse
​
(m. 2022)​
Parent
  • Ene-Obong Effiom Ene-Obong (father)

Abasi Ene-Obong (born 20 June 1985), is a Nigerian biomedical scientist and entrepreneur. [1] Abasi holds a master's degree in human molecular genetics from Imperial College London and a PhD in Cancer Biology from Barts and The London School of Medicine and Dentistry in England. [2] Since September 2023, he is the founder and CEO of Syndicate Bio, a health technology company driving genomics and precision medicine initiatives in global healthcare. [3] [4] Prior to this, since 2019, Abasi served as the co-founder and CEO at 54Gene Inc, a defunct Nigerian health and biotech firm specialized in African genomics which he grew to a valuation of nearly $200m before stepping down in October 2022. [5] [6]

Contents

Biography

Abasi was born on 20 June 1985, to Prof Mrs Henrietta Nkechi Ene-obong and late Prof. Ene-Obong Effiom Ene-Obong, he was raised in Nsukka, Nigeria. Both parents were/ are members of the Nigerian Academy of Science. His father served as vice chancellor at University of Cross River State, and a traditional ruler in Calabar among others. [7] [8]

In 2003, Abasi attended his undergraduate studies at University of Calabar, Nigeria where he obtained a Bachelor of Sciences in Genetics and Biotechnology in 2007. Subsequently, he enrolled at Imperial College London, UK to pursue a post-graduate degree, he graduated with master's degree in human molecular genetics. Since 2013, Abasi holds a PhD in Cancer Biology from Barts and The London School of Medicine and Dentistry in England. Abasi further enrolled at Claremont Colleges, U.S to pursue another post graduate degree, he graduated with master's in business management in 2014. [9] [10]

Career

Since 2009, Abasi was a researcher, working at King's College London until 2010, and Barts Cancer Institute until 2013. He is published in some of the world's scientific journals such as Gastroenterology, Cell, and Nature. In 2013, he published in Gastroenterology Journal a paper on pancreatic cancer immunology. [11] In 2021, Abasi was invited by Nature Biotech, alongside Bill Gates, Jennifer Doudna, and others to co-author the "Voices of biotech" issue. [12] From 2013 to 2014, Abasi served as a consultant for Panasonic and Gilead Sciences. Between 2014 and 2015, Abasi was a research director and consultant at IMS Health (now known as IQVIA), based in the U.S. Subsequently, he became a PricewaterhouseCoopers (PwC) senior associate and healthcare industry advisor, based in the U.S, until August 2016. In 2017, Abasi spent months as a Lead Consultant at Pathfinder International for Nigeria's Strategic Health Development Plan, based in Nigeria. [13]

Business career

54Gene

In 2019, Abasi founded 54gene in Nigeria along with Ogochukwu Osifo, Damilola Oni, and Gatumi Aliyu, to address the neglect of African natives in global genomics research by setting out the authoritative biobank of the African genome among other initiatives. [14] [15] He served as the CEO of 54gene until October 2022. [16] In 2020, Abasi and his team raised a $15 million Series A round led by Adjuvant Capital to scale research operations and clinical programs. [17] Backed by notable investors including Y Combinator, in two years they raised $45 million in three funding rounds to implement in African genomics, considered the first of its kind in Africa. [18] [19] In September 2020, Abasi joined the Endeavor Entrepreneur global network, 54gene joined 10 other Endeavor Entrepreneur-led companies in Nigeria, and over 1,300 in Endeavor's 37 markets across Africa, Latin America, Asia, Europe and North America. [20]

During the COVID-19 pandemic, 54gene built resources around COVID-19 testing, setting up testing labs and mobile labs in Nigeria . [21] They were at some point one of Nigeria's largest providers of COVID testing. [22] In August 2022, with the significant decline in COVID-19 tests, the 54gene laid off 30% of its workforce, many company employees were recruited in relation to COVID-19 operations. In October 2022, Abasi resigned from CEO position and was replaced by Teresia L. Bost as interim CEO. [23]

Syndicate Bio

In September 2023, Abasi launched Syndicate Bio, a health technology company driving genomics and precision medicine initiatives across the world's most diverse regions, starting in Africa to bridge the gap in global healthcare. [24] Through Syndicate Bio, Abasi uses partnerships with governments, pharma companies, academia and other stakeholders to drive local precision medicine impact. In October 2023, Syndicate Bio announced the signing of MoU with the Nigerian Institute of Medical Research (NIMR). [25] In April 2024, Sophia Genetics and Syndicate Bio announced a collaboration to introduce comprehensive genomic profiling and liquid biopsy services on an unprecedented scale across Africa. [26] [27]

Scientific contributions with 54gene

In 2019, Abasi through 54gene started developing the pan-African DNA biobank, the first of its kind which collected above 300,000 unique human samples and corresponding genomic data by 2022. [28] [29] Abasi through 54gene created the African Center for Translational Genomics (ACTG). The ACTG was launched as a Non-profit organization to harness translational genetic research across Africa by providing grants, fellowships, internships, and training to medical students and researchers. [30] In February 2020, Abasi led 54gene to team up with Nigerian scientists to launch a study investigating genetic causes of non-communicable diseases in Nigeria. [31] [32]

During COVID-19 pandemic, Abasi through 54gene raised Nigeria's COVID-19 testing capacity. In March 2020, he launched a $500,000 fund to tackle COVID-19 testing challenges faced in Nigeria, 54gene opened the fund by donating $150,000 within 24 hours, he had secured an additional of $350,000 from partners, including Union Bank. Since April 2020, 54gene started launching mobile laboratories in Nigeria. The mobile labs were fully kitted container structures designed to reduce the logistical challenges involved in shipping samples to another location for processing. [33] [34]

Memberships

Recognitions

2019: One of the 30 most innovative entrepreneurs of the year in Africa by Quartz. [37]

2020: Fortune's 40 under 40 most influential people in healthcare. [38]

2020: Nigeria Hero in the fight against COVID-19 by This Day. [39]

2021: One of the 100 most influential young Africans by Avance Media. [40]

2021: Technology Pioneers by World Economic Forum. [41]

2021: Young Global Leaders by World Economic Forum. [42]

2021: New Economy Catalyst by Bloomberg. [43]

2022: Top 20 under 40 biotech leaders by Endpoint News. [44]

Personal life

Abasi is married to Ini Dima-Okojie, a couple got legally married on May 19, 2022, and traditionally on May 21, 2022, in Lagos, Nigeria. [45]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Pfizer</span> American multinational pharmaceutical and biotechnology corporation

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

<span class="mw-page-title-main">AstraZeneca</span> British pharmaceutical company

AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

<span class="mw-page-title-main">Amgen</span> American multinational biopharmaceutical company

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000 and included hundreds of scientists, making Amgen the largest employer in Ventura County. As of 2022, Amgen has approximately 24,000 staff in total.

<span class="mw-page-title-main">George Church (geneticist)</span> American geneticist

George McDonald Church is an American geneticist, molecular engineer, chemist, serial entrepreneur, and pioneer in personal genomics and synthetic biology. He is the Robert Winthrop Professor of Genetics at Harvard Medical School, Professor of Health Sciences and Technology at Harvard University and Massachusetts Institute of Technology, and a founding member of the Wyss Institute for Biologically Inspired Engineering at Harvard University.

<span class="mw-page-title-main">23andMe</span> American personal genomics company

23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.

<span class="mw-page-title-main">Patrick Soon-Shiong</span> South African billionaire physician, CEO & philanthropist (b. 1952)

Patrick Soon-Shiong is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

<span class="mw-page-title-main">Moderna</span> American biotechnology company

Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

Jumia is a Pan-African technology company that is built around a marketplace, logistics service and payment service. The logistics service enables the delivery of packages through a network of local partners while the payment services facilitate the payments of online transactions within Jumia’s ecosystem. It has partnered with more than 100,000 active sellers and individuals.

Tute Genomics is a genomics startup that provides a cloud-based web application for rapid and accurate annotation of human genomic data. Built on the expertise of ANNOVAR, Tute assists researchers in identifying disease genes and biomarkers, and assists clinicians/labs in performing genetic diagnosis. Based in Provo, Utah, Tute was co-founded by Dr. Kai Wang, an Assistant Professor at the University of Southern California (USC); and Dr. Reid J. Robison, a board-certified psychiatrist with fellowship training in both neurodevelopmental genetics and bioinformatics.

Human Longevity, Inc. is a San Diego-based venture launched by Craig Venter and Peter Diamandis in 2013. Its goal is to build the world's most comprehensive database on human genotypes and phenotypes, and then subject it to machine learning so that it can help develop new ways to fight diseases associated with aging. The company received US$80 million in investments in its Series A offering in summer 2014 and announced a further $220 million Series B investment offering in April 2016. It has made deals with drug companies Celgene and AstraZeneca to collaborate in its research.

Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.

Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy.

Cathy Tie is a Canadian bioinformatician and entrepreneur, the founder of Ranomics, a genetic screening company, and of Locke Bio, a telemedicine company, both based in Toronto.

<span class="mw-page-title-main">10x Genomics</span> American biotechnology company

10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.

Sophia Genetics is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts. It provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017. The company went public on the Nasdaq in 2021, floating at $1.1B.

<span class="mw-page-title-main">GenScript Biotech</span> Biotechnology group

GenScript Biotech, fully known as GenScript Biotech Corporation, usually referred to as simply GenScript, is a New Jersey-based biotech company. It was co-founded in 2002 in New Jersey by Fangliang Zhang, Ye Wang, and Luquan Wang. The company mainly provides life science research application instruments and services. It was listed on the Hong Kong Stock Exchange in 2015. The current rotating CEO of the firm is Shao Weihui, who also served as the chief operating officer and Chinese Communist Party Committee Secretary for the company. The company's main subsidiaries include Legend Biotech, ProBio Technology, and Bestzyme.

<span class="mw-page-title-main">Michelle McMurry-Heath</span> American Immunologist

Michelle McMurry-Heath is a medical doctor, immunologist, and from June 2020 until October 2022 served as chief executive officer for the Biotechnology Innovation Organization (BIO).

The Obong of Calabar is the traditional ruler and custodian of the culture of the Efik people of Western Africa. The Obong is referred to as a natural ruler, treaty King, grand patriarch of the Efik Kingdom and later bestowed with the additional title of defender of the Christian faith by a British monarch owing to the Obong's documented efforts in helping the spread of christianity in his domain. The Efik people are dispersed and settled in many parts of south eastern Nigeria and southwestern Cameroun but are mostly Centred in Calabar, capital of Cross River State. Calabar which was named by the Portuguese was locally known as Ata Akpa in local Efik language.

Prenetics is a Hong Kong company that offers genetic profiling services.

References

  1. ↑ Oluwole, Victor (5 July 2021). "The people behind healthcare innovation: an interview with Abasi Ene-Obong, CEO and Founder, 54gene". Business Insider Africa. Retrieved 21 May 2024.
  2. ↑ Marcus, Joy (21 July 2019). "Infrastructure gap makes working in Nigeria challenging – Abasi Ene-Obong". Punch Newspapers. Retrieved 21 May 2024.
  3. ↑ Omoniyi, Faith (19 September 2023). "Ex CEO of 54gene launches new genomics startup". TechCabal. Retrieved 21 May 2024.
  4. ↑ "54gene Founder Returns With New Genomics Company Syndicate Bio". POCIT. Telling the stories and thoughts of people of color in tech. 21 September 2023. Retrieved 21 May 2024.
  5. ↑ Walt, Vivienne (7 August 2022). "54gene's CEO Wants to Fix Health Data's Racial Imbalance". TIME. Retrieved 23 May 2024.
  6. ↑ "It's 54gene's Abasi Ene-Obong again – Technext". 20 September 2023. Retrieved 24 May 2024.
  7. ↑ "Inidima Okojie Loses Father-in-law | Independent Newspaper Nigeria". 23 September 2023. Retrieved 21 May 2024.
  8. ↑ "CRUTECH VC Capped Etubom By Obong of Calabar". CrossRiverWatch. Retrieved 28 May 2024.
  9. ↑ Porta, Lauren (11 August 2022). "KGI Alum and 54gene CEO Abasi Ene-Obong Wants to Fix the Racial Imbalance in Health Data". Keck Graduate Institute. Retrieved 21 May 2024.
  10. ↑ Porta, Lauren (13 April 2022). "KGI Announces Alumnus Dr. Abasi Ene-Obong as the School of Pharmacy and Health Sciences 2022 Commencement Speaker". Keck Graduate Institute. Retrieved 22 May 2024.
  11. ↑ Ene-Obong, Abasi; Clear, Andrew J.; Watt, Jennifer; Wang, Jun; Fatah, Rewas; Riches, John C.; Marshall, John F.; Chin-Aleong, Joanne; Chelala, Claude; Gribben, John G.; Ramsay, Alan G.; Kocher, Hemant M. (1 November 2013). "Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma". Gastroenterology. 145 (5): 1121–1132. doi:10.1053/j.gastro.2013.07.025. ISSN   1528-0012. PMC   3896919 . PMID   23891972.
  12. ↑ Bosley, Katrine; Casebourn, Charlotte; Chan, Priscilla; Chen, Janice; Chen, Michael; Church, George; Cumbers, John; de Wouters, Tomas; Dewey-Hagborg, Heather; Duportet, Xavier; Ene-Obong, Abasi; Elizondo, Arturo; Farrar, Jeremy; Gates, Bill; Gatto, Francesco (1 June 2021). "Voices of biotech leaders". Nature Biotechnology. 39 (6): 654–660. doi:10.1038/s41587-021-00941-4. ISSN   1546-1696.
  13. ↑ Koba, Melchior. "Nigeria: Abasi Ene-Obong fights cancer with biotech solutions". www.wearetech.africa (in French). Retrieved 21 May 2024.
  14. ↑ "The Demise Of 54gene: Insiders Trace How Boom Turned Bust". WeeTracker. 29 September 2023. Retrieved 21 May 2024.
  15. ↑ Udodiong, Inemesit (10 July 2019). "Business Insider chats with the CEO of 54gene, the company building the world's first pan-African biobank". Pulse Nigeria. Retrieved 21 May 2024.
  16. ↑ "How decoding African DNA could help fight disease". BBC News. 12 November 2019. Retrieved 21 May 2024.
  17. ↑ Jackson, Tom (14 April 2020). "Nigeria's 54gene secures $15m Series A funding round to scale operations". Disrupt Africa. Retrieved 22 May 2024.
  18. ↑ "Erstwhile co-founder and CEO of 54gene launches Syndicate Bio, another genomics venture". Bendada.com, modern tech media in SSA. 18 September 2023. Retrieved 21 May 2024.
  19. ↑ Eleanya, Frank (22 January 2021). "54gene's new genomic lab holds promise for Nigeria's medical research". Businessday NG. Retrieved 21 May 2024.
  20. ↑ "Dr. Abasi Ene-Obong, Founder And CEO Of 54gene Selected As Endeavor Entrepreneur". 21 September 2020. Retrieved 21 May 2024.
  21. ↑ Jackson, Tom (29 April 2020). "Nigeria's 54gene launches mobile COVID-19 testing lab". Disrupt Africa. Retrieved 22 May 2024.
  22. ↑ Kene-Okafor, Tage (29 August 2022). "African genomics startup 54gene lays off 95". TechCrunch. Retrieved 22 May 2024.
  23. ↑ Augustine, Abraham (25 October 2022). "54gene CEO steps down 2 months after the company laid off 30% of its workforce". TechCabal. Retrieved 21 May 2024.
  24. ↑ Nwankwo, Joel (19 September 2023). "Former CEO of 54Gene Launches Syndicate Bio, to Spearhead Genomics in Africa". Tech | Business | Economy. Retrieved 21 May 2024.
  25. ↑ "Syndicate Bio Scores Early Win As 54gene Ex-CEO Plots Comeback". WeeTracker. 18 October 2023. Retrieved 21 May 2024.
  26. ↑ "Nigerian biotech startup, Syndicate Bio, introduces liquid biopsy services to revolutionize cancer diagnostics in Africa". innovation-village.com. Retrieved 21 May 2024.
  27. ↑ GENETICS, SOPHiA. "SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa". www.prnewswire.com. Retrieved 22 May 2024.
  28. ↑ Eyimegwu, Ekene (21 April 2022). "54gene, Health Technology Startup". Connectnigeria Articles. Retrieved 23 May 2024.
  29. ↑ Pedroncelli, Peter (27 May 2020). "TRUE Africa | African Genomics Firm 54gene Raises $15M To Accelerate African Genetic Research". TRUE Africa. Retrieved 23 May 2024.
  30. ↑ "Nigerian Startup 54gene Launches the African Centre for Translational Genomics". Ash Publications. 30 December 2021.
  31. ↑ Williams, Tommy. "Meet 54Gene: Changing The Landscape Of Global DNA By Including Africa". Forbes. Retrieved 23 May 2024.
  32. ↑ Letsebe, Kgaogelo (12 May 2022). "Nigerian 100K genome project on track to completion". Research Professional News. Retrieved 23 May 2024.
  33. ↑ Anudu, Odinaka (18 May 2020). "How Ene-Obong raises Nigeria's Covid-19 testing capacity". Businessday NG. Retrieved 21 May 2024.
  34. ↑ Adejoro, Lara (21 July 2020). "We've stopped N50,000 extra charges for COVID-19 test −54gene CEO". Punch Newspapers. Retrieved 21 May 2024.
  35. ↑ "International Cancer Coalition Members". Bloomberg New Economy. Retrieved 30 May 2024.
  36. ↑ Media, Bloomberg. "Fourth Annual Bloomberg New Economy Forum Announces New Programming and Initiatives Leading Delegate Action on Finance, Cities, Trade, Climate and Health, November 16–19 in Singapore". www.prnewswire.com. Retrieved 28 May 2024.
  37. ↑ "Quartz Africa Innovators 2019: leading the change for Africa's future". Quartz. 19 September 2019. Retrieved 21 May 2024.
  38. ↑ BellaNaija.com (5 September 2020). "Margaret Anadu, Abasi Ene-Obong & Olugbenga Agboola make "Fortune 40 under 40" 2020 List". BellaNaija. Retrieved 21 May 2024.
  39. ↑ "Fighting for Nigeria: Heroes of Battle against COVID-19 – THISDAYLIVE". www.thisdaylive.com. Retrieved 28 May 2024.
  40. ↑ Nsehe, Mfonobong. "After Raising $4.5 Million, 54gene Seeks To Lead Genetic Mapping Of African DNA". Forbes. Retrieved 21 May 2024.
  41. ↑ Jackson, Tom (16 June 2021). "7 African startups named WEF Technology Pioneers of 2021". Disrupt Africa. Retrieved 28 May 2024.
  42. ↑ Admin (18 March 2021). "WEF Confers Two Young Enterprising Nigerians with Aliko Dangote Fellowship". African Leadership Magazine. Retrieved 28 May 2024.
  43. ↑ "Introducing the First Bloomberg New Economy Catalysts". Bloomberg New Economy. 8 June 2021. Retrieved 28 May 2024.
  44. ↑ "The 20(+1) under 40: Your guide to the next generation of biotech leaders". Endpoints News. Retrieved 28 May 2024.
  45. ↑ BellaNaija.com (26 May 2022). "Ini Dima-Okojie & Abasi Ene-Obong's Traditional Wedding was an Awesome Display of Love & Culture". BellaNaija. Retrieved 23 May 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.